Takeda Vaccines Head: Peer Review Process For COVID-19 Vaccines Must Be 'Very Open'

 
• By Anju Ghangurde
  
COVID-19 Vaccine. Corona Virus SARS-CoV-2, 2019 nCoV virus destruction. A vaccine against coronavirus disease 2019. Breakthrough in the Creating of a COVID-19 Vaccine.
Transparency About COVID-19 Vaccine Data Vital, Says Takeda Executive • Source: Shutterstock

More from Business

More from Scrip